About the Authors
- Laura M. Lopez-Sánchez
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Carla Jimenez
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Araceli Valverde
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Vanessa Hernandez
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Jon Peñarando
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Antonio Martinez
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Chary Lopez-Pedrera
-
Affiliation Research Unit, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain
- Juan R. Muñoz-Castañeda
-
Affiliation Research Unit, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain
- Juan R. De la Haba-Rodríguez
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Enrique Aranda
-
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
- Antonio Rodriguez-Ariza
-
* E-mail: antonio.rodriguez.exts@juntadeandalucia.es
Affiliations Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: AR-A LML-S JRM-C. Performed the experiments: LML-S CJ AV VH JP AM. Analyzed the data: LML-S CJ AM CL-P JRM-C JRH-R EA AR-A. Contributed reagents/materials/analysis tools: AR-A AM EA. Contributed to the writing of the manuscript: LML-S CL-P JRM-C AR-A.